Zimmermann, Thomas

Medically Unexplained Physical Symptoms, Anxiety, and Depression: A Meta-Analytic Review

Henningsen, P., Zimmermann, T., & Sattel, H. (2003) · Psychosomatic Medicine

Psychosomatic Disorders and Their TreatmentsFibromyalgia and Chronic Fatigue Syndrome Research

Cited by 829

Cholinesterase inhibitors for patients with Alzheimer's disease: systematic review of randomised clinical trials

Kaduszkiewicz, H., Zimmermann, T., Beck-Bornholdt, H.-P., & van den Bussche, H. (2005) · BMJ

Cholinesterase and Neurodegenerative DiseasesDementia and Cognitive Impairment Research

Cited by 522

Thioacetamide-induced cirrhosis-like liver lesions in rats usefulness and reliability of this animal model

Müller, A., Machnik, F., Zimmermann, T., & Schubert, H. (1988) · Experimental Pathology

Liver physiology and pathologyDrug-Induced Hepatotoxicity and Protection

Cited by 182

Collaborative nurse-led self-management support for primary care patients with anxiety, depressive or somatic symptoms: Cluster-randomised controlled trial (findings of the SMADS study)

Zimmermann, T., Puschmann, E., van den Bussche, H., Wiese, B., Ernst, A., Porzelt, S., Daubmann, A., & Scherer, M. (2016) · International Journal of Nursing Studies

Nursing Roles and PracticesDiabetes Management and Education

Cited by 62

Lipoprotein apheresis is an optimal therapeutic option to reduce increased Lp(a) levels

Scientific Board of GLAR for the German Apheresis Working Group, Schettler, V. J. J., Neumann, C. L., Peter, C., Zimmermann, T., Julius, U., Hohenstein, B., Roeseler, E., Heigl, F., Grützmacher, P., et al. (2019) · Clinical Research in Cardiology Supplements

Lipoproteins and Cardiovascular HealthAtherosclerosis and Cardiovascular Diseases

Cited by 37

Diagnostic and treatment barriers to persistent somatic symptoms in primary care - representative survey with physicians

Lehmann, M., Pohontsch, N. J., Zimmermann, T., Scherer, M., & Löwe, B. (2021) · BMC Family Practice

Psychosomatic Disorders and Their TreatmentsPrimary Care and Health Outcomes

Cited by 37

The Assessment of Changes in Cognitive Functioning: Age-, Education-, and Gender-Specific Reliable Change Indices for Older Adults Tested on the CERAD-NP Battery: Results of the German Study on Ageing, Cognition, and Dementia in Primary Care Patients (AgeCoDe)

Stein, J., Luppa, M., Luck, T., Maier, W., Wagner, M., Daerr, M., van den Bussche, H., Zimmermann, T., Köhler, M., Bickel, H., et al. (2012) · The American Journal of Geriatric Psychiatry

Dementia and Cognitive Impairment ResearchHistorical and Modern Theater Studies

Cited by 35

Oligoclonal bands and kappa free light chains: Competing parameters or complementary biomarkers?

Konen, F. F., Wurster, U., Schwenkenbecher, P., Gerritzen, A., Groß, C. C., Eichhorn, P., Harrer, A., Isenmann, S., Lewczuk, P., Lewerenz, J., et al. (2025) · Autoimmunity Reviews

Multiple Sclerosis Research StudiesPeripheral Neuropathies and Disorders

Cited by 31